Double-take: SARS-CoV-2 has evolved to evade human innate immunity, twice

Trends Immunol. 2023 Dec 23:S1471-4906(23)00261-2. doi: 10.1016/j.it.2023.12.001. Online ahead of print.ABSTRACTSequential replacement of the dominant SARS-CoV-2 virus by new variants has been a striking feature of the COVID-19 pandemic. In two recent articles, Bouhaddou et al. and Kehrer et al. demonstrate that, like the original virus, the SARS-CoV-2 omicron strain has progressively evolved to evade host innate immune defenses.PMID:38143224 | DOI:10.1016/j.it.2023.12.001
Source: Trends in Immunology - Category: Allergy & Immunology Authors: Source Type: research